Regulation of the United Kingdom biotechnology industry and global competitiveness.

  • Great Britain. Parliament. House of Lords. Science and Technology Committee.
Date:
[1993]
Catalogue details

Licence: Open Government Licence

Credit: Regulation of the United Kingdom biotechnology industry and global competitiveness. Source: Wellcome Collection.

    6/100 (page 4)
    The deliberate release regulations 235/04 44;.c ns ee as ee O.2e Process regulation and product regulation” 2s ays wa as ae 6.27 Regulation and competitiveness : .: Po \iWaciaae eo. es woe eau cee eee ees 6.32 Public understanding -.:.o.c5.0% 5. ge azie «'- varns Se rere ee ae oe 6.42 CHAPTER 7 SUMMARY OF CONCLUSIONS AND RECOMMENDATIONS . 7. Gomera is. siaeis ss nie Sle eee oa sense wr eae at em i os a dal Contained use ......... WRADAAL EE TASER See Oct F. . ora sheer aa 7.8 Deliberate release (32. ofa cet ale» eee ee Oe ee eee ae Process regulation and product regulation ................ eee ceceeeeees 7.17 Regulation and competitiveness .... 6.6. .0us. +6. <= +6 5 ee oe 7.20 Publictunderstanding 20 Jiu. van ute ee oe nada, & RN paiahia leaned ant 7.24 APPENDIX 1 Membership of Sub-Committee TT... 1.1... wee ee eens APPENDIX 2 Invitation to submit written evidence (United Kingdom) ............ APPENDIX 3 Invitation to submit written evidence (Foreign) ................2-. APPENDIX 4 Comparison of regulation of new biotechnologies in major industrialised countries |v o.'.3% . . a. o< 4 on ee ee ee APPENDIX 5 Acronyms ...... TCE Ce Fe ee a ee APPENDES6, Glossary, ooo06 sigs <5 39 44% cee» ella ors Mine rene eee a APPENDIX:7, List of witnesses ... . 0222.2 +4tss acs 5 oe Centre le iernnl References in the text are as follows: (Q) refers to a question in oral evidence. (p) refers to a page in HL Paper 80-I. (P) refers to a page in HL Paper 80-II. Written evidence received up to 30 April 1993 - HL Paper 80-I 56 58 59 60 62 62 62 62 63 63 63 65 65 67 87 91